Dr Manikanta Receives AHA Fellowship to Investigate Platelet-Dependent Nucleic Acid-Sensing Pathways
Versiti Blood Research Institute shared on LinkedIn:
”Congratulations to Manikanta ., PhD, a postdoctoral fellow in Prithu Sundd, PhD’s lab, on receiving a two-year American Heart Association (AHA) Postdoctoral fellowship totaling $156,000.
Through this AHA fellowship, Dr. Manikanta will investigate how platelet-dependent nucleic acid-sensing pathways contribute to the development of lung thrombosis in sickle cell disease. (Lung thrombosis is the formation of dangerous blood clots in the lungs.)
The long-term goal of this project is to reduce life-threatening complications in high-rick sickle cell disease patients.
But what makes this work unique to VBRI is the collaborative ecosystem powering it.
This project brings together VBRI scientists, MCW/Froedtert Adult Sickle Cell Clinic, the Versiti-Clinical Trials Research Office (CTRO), along with new resources available at Versiti on King and the inception of the MCW Sickle Cell Bio Bank.
Together, these necessary resources enable translational research that connects the research in lab to patient care in the clinic.
“A collaborative team effort on such scale is hard to envision anywhere else in this country,” says Dr. Manikanta.
Collaborators on this project (“Platelet-dependent Nucleic Acid Sensing Promotes Pulmonary Thrombosis in Sickle Cell Disease”) include Tomasz Kaminski, PhD, and Joshua Field, MD.”
More winner stories featured in Hemostasis Today.
-
Sep 1, 2026, 04:27Ruth Fein: The Patient Impact of Transfusion Dependence in Myelofibrosis
-
Sep 1, 2026, 02:41Richard Buka: Win a Trip to ASH or ISTH 2027
-
Sep 1, 2026, 02:38Christian’s Journey to Stability on Avatrombopag – ITP Support Association
-
Sep 1, 2026, 02:35Alexis Guédon: Is IL-6 Pathway Inhibition Reduce Cardiovascular Risk in Giant Cell Arteritis?
-
Aug 31, 2026, 17:11Chokri Ben Lamine: Early Recognition and Immediate Treatment of Catastrophic APS
-
Aug 31, 2026, 17:06Nikolaos Ktenopoulos: COMPASS-ARTeCAT Trial Highlights Arterial Thrombosis in Patients With Cancer
-
Aug 31, 2026, 17:01Mark Kaplan: Same LDL-C, Different Coagulation, Different Outcomes, in FH
-
Aug 31, 2026, 16:55Kemal Karaagac: Milvexian Did Not Reduce Ischemic Events but Did Not Increase Fatal Bleeding
-
Aug 31, 2026, 16:47Improving Outcomes in AF-Related Stroke Beyond Anticoagulation at ESC 2026 – ESO